Benyi Li

4.0k total citations
85 papers, 3.2k citations indexed

About

Benyi Li is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Benyi Li has authored 85 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 33 papers in Pulmonary and Respiratory Medicine and 15 papers in Cancer Research. Recurrent topics in Benyi Li's work include Prostate Cancer Treatment and Research (25 papers), Ubiquitin and proteasome pathways (11 papers) and RNA Interference and Gene Delivery (9 papers). Benyi Li is often cited by papers focused on Prostate Cancer Treatment and Research (25 papers), Ubiquitin and proteasome pathways (11 papers) and RNA Interference and Gene Delivery (9 papers). Benyi Li collaborates with scholars based in United States, China and Japan. Benyi Li's co-authors include Q. Ping Dou, J. Brantley Thrasher, Xinbo Liao, Chaoyang Li, Aijing Sun, J.M. Holzbeierlein, Paul F. Terranova, Jihong Liu, Jun Yang and Simin Liu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and PLoS ONE.

In The Last Decade

Benyi Li

82 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benyi Li United States 31 2.0k 633 618 421 350 85 3.2k
Qihan Dong Australia 29 1.4k 0.7× 255 0.4× 631 1.0× 405 1.0× 311 0.9× 83 2.5k
Xi Yang China 28 1.9k 0.9× 1.3k 2.1× 454 0.7× 885 2.1× 460 1.3× 144 3.6k
Yi Luo China 32 1.8k 0.9× 660 1.0× 854 1.4× 756 1.8× 247 0.7× 149 4.3k
Bangyan L. Stiles United States 30 3.1k 1.6× 341 0.5× 871 1.4× 895 2.1× 281 0.8× 57 4.7k
Fei Chen China 30 1.9k 0.9× 245 0.4× 521 0.8× 472 1.1× 163 0.5× 114 3.3k
Shizhong Bu China 30 1.5k 0.8× 250 0.4× 298 0.5× 626 1.5× 222 0.6× 86 2.6k
George Kulik United States 22 1.7k 0.8× 321 0.5× 568 0.9× 442 1.0× 306 0.9× 38 2.7k
Yan Gong China 33 1.8k 0.9× 654 1.0× 627 1.0× 639 1.5× 179 0.5× 160 3.3k
Mauro Bologna Italy 36 1.7k 0.8× 789 1.2× 1.1k 1.8× 722 1.7× 177 0.5× 116 3.5k
Min‐Wei Chen China 27 1.3k 0.7× 676 1.1× 460 0.7× 411 1.0× 129 0.4× 56 2.4k

Countries citing papers authored by Benyi Li

Since Specialization
Citations

This map shows the geographic impact of Benyi Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benyi Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benyi Li more than expected).

Fields of papers citing papers by Benyi Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benyi Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benyi Li. The network helps show where Benyi Li may publish in the future.

Co-authorship network of co-authors of Benyi Li

This figure shows the co-authorship network connecting the top 25 collaborators of Benyi Li. A scholar is included among the top collaborators of Benyi Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benyi Li. Benyi Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Hua, Huibo Lian, Wang Liu, et al.. (2025). Sideroflexin family genes were dysregulated and associated with tumor progression in prostate cancers. Human Genomics. 19(1). 10–10. 1 indexed citations
2.
Zhou, Mi, Chengfei Yang, Yang‐Wuyue Liu, et al.. (2025). S100A9 as a potential novel target for experimental autoimmune cystitis and interstitial cystitis/bladder pain syndrome. Biomarker Research. 13(1). 72–72. 1 indexed citations
3.
Zhao, Jiang, Qian Zhang, Yuqi Wu, et al.. (2024). Prognostic feature based on androgen-responsive genes in bladder cancer and screening for potential targeted drugs. BioData Mining. 17(1). 59–59.
4.
Li, Benyi, et al.. (2024). Sideroflexin family genes in human diseases: an update. LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas). 1(1).
5.
Huang, Shengnan, Jinxin Miao, Xiali Zhu, et al.. (2023). Red blood cell membrane-coated functionalized Au nanocage as a biomimetic platform for improved MicroRNA delivery in hepatocellular carcinoma. International Journal of Pharmaceutics. 642. 123044–123044. 14 indexed citations
6.
He, Chenchen, et al.. (2023). Jumonji domain-containing protein RIOX2 is overexpressed and associated with worse survival outcomes in prostate cancers. Frontiers in Oncology. 13. 1087082–1087082. 1 indexed citations
7.
Huang, Jian, et al.. (2022). The iron-modulating hormone hepcidin is upregulated and associated with poor survival outcomes in renal clear cell carcinoma. Frontiers in Pharmacology. 13. 1080055–1080055. 6 indexed citations
8.
Chang, Tao, Wang Liu, Xiang Yan, et al.. (2022). PAQR5 Expression Is Suppressed by TGFβ1 and Associated With a Poor Survival Outcome in Renal Clear Cell Carcinoma. Frontiers in Oncology. 11. 827344–827344. 9 indexed citations
9.
Zhu, Runzhi, Jingxia Chang, Haixia Xu, et al.. (2021). The Orphan Nuclear Receptor Gene NR0B2 Is a Favorite Prognosis Factor Modulated by Multiple Cellular Signal Pathways in Human Liver Cancers. Frontiers in Oncology. 11. 691199–691199. 9 indexed citations
10.
Liu, Wang, et al.. (2020). Alternol/Alteronol: Potent Anti-cancer Compounds With Multiple Mechanistic Actions. Frontiers in Oncology. 10. 568110–568110. 3 indexed citations
11.
Yang, Yinhui, Yang Bai, Yundong He, et al.. (2017). PTEN Loss Promotes Intratumoral Androgen Synthesis and Tumor Microenvironment Remodeling via Aberrant Activation of RUNX2 in Castration-Resistant Prostate Cancer. Clinical Cancer Research. 24(4). 834–846. 50 indexed citations
12.
Chen, Ruibao, Xing Zeng, Ruitao Zhang, et al.. (2013). Cav1.3 channel α1D protein is overexpressed and modulates androgen receptor transactivation in prostate cancers. Urologic Oncology Seminars and Original Investigations. 32(5). 524–536. 60 indexed citations
13.
Yao, Kai, Hyewon Youn, Xiaoyan Gao, et al.. (2012). Casein kinase 2 inhibition attenuates androgen receptor function and cell proliferation in prostate cancer cells. The Prostate. 72(13). 1423–1430. 23 indexed citations
14.
Tai, Wanyi, Ravi Shukla, Bin Qin, Benyi Li, & Kun Cheng. (2011). Development of a Peptide–Drug Conjugate for Prostate Cancer Therapy. Molecular Pharmaceutics. 8(3). 901–912. 76 indexed citations
15.
Zheng, Xiaoqing, et al.. (2009). The calcimimetic R-568 induces apoptotic cell death in prostate cancer cells. Journal of Experimental & Clinical Cancer Research. 28(1). 100–100. 6 indexed citations
16.
17.
Sun, Aijing, Ossama Tawfik, Bishoy A. Gayed, et al.. (2006). Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers. The Prostate. 67(2). 203–213. 103 indexed citations
18.
Liao, Xinbo, J. Brantley Thrasher, J.M. Holzbeierlein, Scott M. Stanley, & Benyi Li. (2004). Glycogen Synthase Kinase-3β Activity Is Required for Androgen-Stimulated Gene Expression in Prostate Cancer. Endocrinology. 145(6). 2941–2949. 73 indexed citations
19.
Li, Benyi, et al.. (1998). Reciprocal expression of bcl-2 and p53 oncoproteins in urothelial dysplasia and carcinoma of the urinary bladder. Urological Research. 26(4). 235–241. 25 indexed citations
20.
Kanamaru, Hiroshi, et al.. (1996). Promoting Effect of Unilateral Nephrectomy on Urinary Bladder Carcinogenesis in Rats. Japanese Journal of Cancer Research. 87(11). 1121–1124. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qihan Dong Breakdown of academic impact, for papers by Xi Yang Breakdown of academic impact, for papers by Yi Luo Breakdown of academic impact, for papers by Bangyan L. Stiles Breakdown of academic impact, for papers by Fei Chen Breakdown of academic impact, for papers by Shizhong Bu Breakdown of academic impact, for papers by George Kulik Breakdown of academic impact, for papers by Yan Gong Breakdown of academic impact, for papers by Mauro Bologna Breakdown of academic impact, for papers by Min‐Wei Chen
Rankless by CCL
2026